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Graphical abstract 
 
 
 
 
Abstract 
 
Glycemic control in intensive care patients is complex in terms of patients’ response to 
care and treatment. The variability and the search for improved insulin therapy outcomes 
have led to the use of human physiology model based on per-patient metabolic 
condition to provide personalized automated recommendations. One of the most 
promising solutions for this is the STAR protocol, which is based on a clinically validated 
insulin-nutrition-glucose physiological model. However, this approach does not consider 
demographical background such as age, weight, height, and ethnicity. This article 
presents the extension to intensive care personalized solution by integrating per-patient 
demographical, and upon admission information to intensive care conditions to 
automate decision support for clinical staff. In this context, a virtual study was conducted 
on 210 retrospectives intensive care patients’ data. To provide a ground, the integration 
concept is presented roughly, but the details are given in terms of a proof of concept 
using Bayesian Network, linking the admission background and performance of the STAR 
control. The proof of concept shows 71.43% and 73.90% overall inference precision, and 
reliability, respectively, on the test dataset. With more data, improved Bayesian Network is 
believed to be reproduced. These results, nevertheless, points at the feasibility of the 
network to act as an effective classifier using intensive care units data, and glycemic 
control performance to be the basis of a probabilistic, personalized, and automated 
decision support in the intensive care units.  
 
Keywords: Personalized Medicine Approach, Glycemic Control, Intensive Care Unit, 
Decision Support, Bayesian Network 
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Abstrak 
 
Kawalan glisemik dalam pesakit kritikal di unit rawatan rapi adalah rumit dari segi tindak 
balas pesakit terhadap penjagaan dan rawatan. Sifat keberubahan individu dan 
pencarian hasil terapi insulin yang lebih baik telah membawa kepada penggunaan 
model matematik fisiologi manusia berdasarkan keadaan metabolik pesakit untuk 
memberikan cadangan rawatan secara individu. Salah satu penyelesaian yang paling 
menjanjikan harapan adalah protokol STAR yang berdasarkan kepada model fisiologi 
insulin-nutrisi-glukosa yang telah disahkan secara klinikal. Namun pendekatan ini tidak 
mengambil kira latar belakang demografi seperti umur, berat, ketinggian dan etnik. 
Artikel ini membentangkan lanjutan kepada penyelesaian rawatan secara peribadi 
mereka dengan mengintegrasikan informasi demografi pesakit dan keadaan mereka 
semasa dimasukkan ke dalam unit rawatan rapi untuk mengautomasikan sokongan 
keputusan untuk kakitangan unit. Dalam konteks ini, satu kajian ‘virtual’ dilakukan pada 
data 210 pesaki. Sebagai kajian kes, konsep integrasi dibentangkan secara kasar, tetapi 
butiran diberikan dari segi bukti konsep yang menggunakan Rangkaian Bayesian, 
menghubungkan latar belakang kemasukan ke unit dan prestasi kawalan STAR. Bukti 
kajian kes menunjukkan 71.43% dan 73.90% ketepatan dan kebolehlaksanaan unjuran 
masing-masing dengan dataset ujian. Dengan lebih banyak data, rangkaian Bayesian 
yang lebih baik dipercayai boleh dihasilkan. Walaubagaimanapun, keputusan ini 
menunjukkan kemungkinan rangkaian ini bertindak sebagai pengelas yang berkesan 
dengan menggunakan data dari unit rawatan rapi dan prestasi kawalan glisemik untuk 
menjadi asas sokongan keputusan bersifat probabilistik, peribadi dan automatic dalam 
unit rawatan rapi.  
 
Kata kunci: Pendekatan Perubatan Peribadi, Kawalan Glisemik, Unit Rawatan Rapi, 
Dokongan Keputusan, Rangkaian Bayesia 
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1.0  INTRODUCTION 
 
Since the birth of intensive care medicine, 
researchers tend to study the cause and effect 
results of patients with similar signs and symptoms 
together under diagnoses, such as “sepsis”, 
“diabetic”, and “acute renal failure”. They ignore a 
considerable non-uniformity within these groups in 
terms of individual characteristics; such as age, 
comorbidities condition, genetic predisposition, and 
individual variations in response to treatment. As 
technology and awareness of improved intensive 
care medicine has progressed, increasingly the 
personalized medicinal approach where patients 
must be treated as individuals, and not only with 
medical complications are entering the intensive 
care units (ICUs) [1-3]. However, it is only the 
beginning of glycemic control management, and 
despite the availabilities of automated 
recommendations for treatment, final judgements 
are practically left to the  opinion of experts.  
With the increasing amount of data generated 
from patients, in insulin to control blood glucose (BG) 
treatment strategies, as across all other ICU therapies, 
more and more control models are now being 
computerized [4]. With the objective of obtaining 
better (less hyperglycemia), and safer (less 
hypoglycemia) control, a growing number of ICUs 
are starting to use validated computer algorithms 
with a beneficial effect on a beneficial effect on 
glycemic control such as EndoTool, LOGIC and STAR 
[5-7]. These controls are based on improved clinical 
guidelines as well as improved physiological models, 
but none explicitly consider per-patient 
demographical background, and upon admission 
condition such as comorbidities.  
STAR (Stochastic TARgeted) is a computerized 
glycemic control protocol that is based on insulin 
sensitivity to characterize and forecast changes in 
per-patient metabolic state, and is designed to be 
used in real-time bedside care. Its prediction is based 
on a stochastic model over the 1-3 hours subsequent 
potential variation in per-patient insulin sensitivity [8-
10]. STAR has shown promising results in the ICU, and 
is currently being used in ICUs in Christchurch, New 
Zealand, and Gyula, Hungary. Since December 2016, 
it has been used in an ICU in Malaysia [11]. An 
unpublished study by a Malaysian research team has 
shown that the generalized performance of STAR [12] 
cannot be reproduced on Malaysian patients, and 
this raises the question of demographical impact on 
the population-based prediction algorithm which 
was validated using only Christchurch, New Zealand 
patients.   
The adaptability of STAR includes BG level target 
range, measurement frequency, patient safety within 
a predefined desired risk, and local nutrition 
practices [13-14]. Given the notable differences in 
patient background and clinical environments, 
clinical staff are faced with a complex tradeoff in 
setting these limits: for example to  either set a wider 
range of BG level target to optimize resources, at the 
expense of higher mortality rate [15], or set a narrow 
range which requires higher nurses intervention to 
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ensure insulin treatment, at the expense of 
considerable patients discomfort, additional cost, or 
higher rate of hypoglycemia [16-17]. 
The objective of the study was to look into the 
feasibility of intergrating decision support on STAR 
protocol to decide on STAR options based on 
individual patient background upon ICU admission. 
As a result, the most appropriate patient treatment 
can be selected. Probabilistic Bayesian network [18] 
approach was used to interpret the possible 
relationship between the demographical, and 
admission data with STAR control performance 
variables for its capability to exploit correlation as 
well as causal relationship using intensive care 
patients data [19-21]. A proof of concept on static 
Bayesian inference was provided to prove the said 
feasibility.  
 
 
2.0  METHODOLOGY 
 
2.1  Virtual Simulation Framework 
 
The method used to simulate the respond to 
demographical, and admission data towards any 
glycemic control is a physiological model-based 
virtual trial framework [22-23]. The framework is 
illustrated in Figure 1. Data such as nutrition and 
insulin are required, while record of patient specific 
conditions such as weight, height, and diabetic 
status can be recorded for expert intervention. The 
framework is divided into two stages, (i) Data fitting 
to generate per-patient insulin sensitivity (SI) profiles 
that acted as virtual patients, and (ii) simulation of 
outcomes using generated SI profiles. Glycemic level 
outcomes are a function of insulin sensitivity (SI), its 
variability, and the chosen control. In this study, the 
clinically validated ICING (Intensive Control Insulin-
Nutrition-Glucose) physiological model [9] was used 
to fit any patient data and the chosen control was 
the STAR control. Part of the simulation results 
consisting of mean blood glucose (BG), total hours of 
treatment, and the number of BG measurements 
were incorporated in our decision support model’s 
proof of concept.  
 
2.2  Bayesian Network 
 
Probabilistic Bayesian Network (BN) is a method that 
has various advantages over the stochastic method. 
It offers the flexibility to infer any variable in its model 
with certain confidence instead of fixing input and 
output variables, and has the ability to explain 
inferences using causal relationship in uncertain 
environments [24]. This was used to explore the 
feasibility to build the decision support. Building basic 
BN involves (i) learning process, and (ii) using it for 
inference test. Learning a BN consists of creating the 
qualitative part of the network which is the causal 
structure between variables, commonly known as 
Directed acyclic Graph (DAG), as well as the 
quantitative part of computing the set of conditional 
probability distribution (CPD) of variables. Resulting 
network is used as a classifier to perform probabilistic 
inference from multiple variables, such as calculating 
the value of P (number of BG measurements | 
presence of diabetic). 
 
 
 
Figure 1 The STAR-ICING virtual trial framework used to simulate glycemic control outcomes [16]  
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The primordial step to create BN was to identify the 
variables that define the description (causes), and 
optionally to set a target node. For each type of 
variable, a definition of values is equally important. In 
the ICU, most data comes in continuous form, but BN is 
most efficient when it is created using discrete values. 
Having the variables and their values, BN structure and 
CPD can be learned using different algorithms; from 
supervised, semi-supervised to unsupervised methods 
[25].  To choose the best structure and CPD, the 80:20 
10-fold cross validation test [26] using number of 
measurements as target node was proposed. This 
means that the validation algorithm iteratively selects 10 
different learning and test sets, and based on those, 
learn the network, and test their performance. 
Performances were measured using the overall 
reliability, and precision metrics. Precision is the ratio of 
predictive positive cases to total number of actual 
cases, while reliability is the ratio of predicted positive 
cases to total number of predicted cases.  
 
2.3  Materials 
 
To provide the proof of concept, this case study 
involved 210 retrospective anonymous patient data 
from Hospital Tengku Ampuan Afzan (HTAA), Kuantan. 
Approval NMR-13-1592 was granted for this study by the 
medical research and ethics committee of the Hospital, 
and Ministry of Health, Malaysia. The data was selected 
randomly with skewed distribution on the patients’ age 
and initial blood glucose level. Patients were originally 
treated with sliding scale glycemic control that dosed 
insulin based on patients’ BG level, and previous insulin 
dose. The control was started when patients reached 
BG level superior to 10 mmol/L, and continued to be 
greater than that within 1 hour. To maintain the BG level 
in targeted BG level range, the patient was initially 
monitored hourly until BG level was within the goal for 2 
hours, then every 4 hours. More details are provided in 
[27].  
These patient data was then injected into the STAR-
ICING virtual trial framework to generate not only virtual 
patients, but also simulating their response to STAR 
control which flexibly offers 1-3 hourly treatment. For the 
purpose of this study, the default choice was the l 
longest intervention recommendation (between 3 
hourly, 2 hourly and 1 hourly). BG level target range for 
STAR was set to 6.0 – 10.0 mmol/L following the same 
target range using sliding scale method. Safety 
hypoglycemia risk was set to be less than 5%.  
Once the outcomes were simulated, the 210 patient 
dataset comprising the per-patient demographic, and 
admission input variables were aligned with their STAR 
control simulated performance results. The complete 
dataset were then injected into BayesiaLab 7.0 software 
to discretize the continuous data, to learn the structure 
and CPD, and to test the target node inference 
reliability and precision. The results not only provided 
proof of concept on the feasibility to use this approach 
as STAR control decision support in the ICU, but also the 
perspective for needed improvement. 
 
3.0  RESULTS AND DISCUSSION 
 
The identification of variables and their values from the 
data is the trickiest task. They require expert opinions, 
are obtained through data analysis, or are the union of 
both. The process of identifying the best discrete values 
and the number of values from the variables is a 
precursor towards building the BN. In this proof of 
concept, 10 demographic, and admission background 
variables were chosen to be added to the 3 control 
performance variables. Continuous data was 
discretized using the k-means method [28], limiting the 
discretization to 3 values. A decision was made after 
test results comparison between networks with 2 and 4 
values. 8 out of the 13 proposed variables were 
discretized using this approach. The number of BG 
measurement was chosen as the target node to assess 
the feasibility of predicting the number of nurses’ 
intervention, and the total length of stay, in an effort to 
reduce resources, and discomfort while assuring BG 
level performance is within target range. Table 1 shows 
the variables used in the provision of proof of concept 
as well as their values.  
 
Table 1 Description of variables for proof of concept dataset 
 
No. Variables Values 
1 Number of BG 
measurements 
<69/69-100/>100 
2 Total hours on 
treatment (hours) 
<110.2/110.2-150.4/>150.4 
3 BG Mean (Geometric) 
(mmol/L) 
>10/8-10/6-8 
4 Initial BG values 
(mmol/L) 
>18/14-18/10-18/<10 
5 Diabetic Yes (1)/No (0) 
6 Hypertension Yes (1)/No (0) 
7 Other morbidity Yes/None  
8 Category of admission Surgical/Medical/Others 
9 Gender Female/Male 
10 Age (Years) <43.1/43.1-61.9/>61.9 
11 Height (cm) <128.3/128.3-159.2/>159.2 
12 Weight (kg) <65/65-84.6/>84.6 
13 Ethnicity Malay/Indian/Chinese/Ot
hers 
 
 
The resulting structure of the BN is presented in Figure 
2. The green, red, blue and yellow coloured nodes 
represent the demographic background, admission 
condition, initial BG upon control start up, and the 
simulated outcomes from STAR control variables, 
respectively. “Number of measurements” as target 
node is highlighted in spiraled node. This structure was 
obtained using the Maximum Spanning Tree 
unsupervised learning strategy [295]. It advocates that 
“Diabetes Mellitus” status is central to the control results. 
The outgoing arcs point to the “Number of 
Measurements” as well as “Hypertension, “Initial BG”, 
and “Height”. While the direction of arcs potentially 
indicate causal relationship, such as the one to 
“Number of Measurements”, others are examined as 
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having a strong correlation to the diabetic status, thus 
to the target node. The structure of marginal probability 
distribution is presented in Figure 3. In this patient group, 
63.67% of the patients were admitted due to medical 
complication, and among them, 64.49% were of Malay 
ethnicity. The percentage of diabetic vs. non diabetic, 
and hypertension vs. non hypertension patients are 
about the same. It is also noted that, 87 of the patients 
have both diabetes and hypertension, and this explains 
the high correlation between the two nodes.
   
 
 
 
Figure 2 The Bayesian Network structure 
  
 
 
 
Figure 3 The probabilistic distribution of data of all variables and their states 
 
 
Examples of BN inference results of individual 
patients are shown in Figures 4(a) and (b). Two 
representative patients were chosen based on their 
admission complications. Patient BSL001 is a 70 year 
old man with no diabetes, no hypertension, and no 
other morbidity who was admitted under the 
medical category. Whereas, Patient BSL025 is an 84 
year old Chinese man with diabetes Mellitus, 
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hypertension, and no other morbidity. To observe the 
results, hard evidence are posed per patient specific 
condition data (green bars), their targeted BG 
means, total hours, and number of measurements 
were correctly inferenced (highest probability, blue 
bars) by the BN. 
 
 
 
 
(a) 
 
 
(b) 
 
Figure 4 Examples with two patients’ original demographic and admission conditions; (a) Patients BSL001, and (b) BSL025 
 
 
Figures 5(a) and (b) show the inference results of 
the same patients, with a hard evidence change of 
their diabetic status. The order of probability for 
mean BG, total hours and number of measurements 
are the same, but the percentage for each value is 
different. Interestingly, the probabilities are inversed 
from the initial results between the two patients. This 
highlights the direct impact, and the important 
weightage of diabetic status in the STAR control 
performance and using this BN. Further sensitivity 
analysis on this node and this variable is required to 
obtain a conclusive observation. 
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(a) 
 
 
 
(b) 
 
Figure 5 Examples from the same two patients when their diabetic status evidence are changed; (a) Patients BSL001, and (b) 
BSL025   
 
 
The reliability and precision results on the test 
dataset (20%, are 42 patients) are presented in Table 
2. The numbers in the column represent the actual 
cases in the test dataset, while the numbers in the 
rows represent the number of BN predicted cases. 
The overall precision is 71.43%, with false negative 
rate of 28.7%, and overall reliability is 73.90%. 
Although this result is not enough to confirm good 
performance of this specific network, we argue that it 
is due to the limited size of the data that was used to 
create, and test this BN (210 patients). Learning and 
testing with a bigger dataset will ensure a more 
precise BN, thus becoming the immediate priority in 
validating this approach.  
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Table 2 The target node inference confusion matrix of test 
dataset  
 
Nb. Of 
Occurrence 
<=68.969 (12) <=100.519 (19) >100.519 (11) 
<=68.969 (9) 9 0 0 
<=100.519 (25) 3 16 6 
>100.519 (8) 0 3 5 
 
Reliability <=68.969 (12) <=100.519 (19) >100.519 (11) 
<=68.969 (9) 100.0% 0% 0% 
<=100.519 (25) 12.0% 64.0% 24.0% 
>100.519 (8) 0% 37.5% 62.5% 
 
Precision <=68.969 (12) <=100.519 (19) >100.519 (11) 
<=68.969 (9) 75.0% 0% 0% 
<=100.519 (25) 25.0% 84.2% 54.5% 
>100.519 (8) 0% 15.8% 45.5% 
 
 
4.0  CONCLUSION 
 
In the provision of proof of concept, we first acquired 
the performance of STAR control using virtual trial 
framework on 210 patient data, and then aligned 
the performance results with demographic, and 
admission information to build a Bayesian Network. 
This is the first step towards building a decision 
support system to be paired with the STAR control 
taking into account the personalized per-patient 
background. Based on the inference test, the BN that 
was developed is capable of classifying the control 
results correctly; “Number of Measurements”, “Total 
Hours” and “BG Mean”. It serves as the proof of 
concept to explore this method, and its integration in 
STAR control further. The real advantage lies in using 
these models as an inference tool for real time 
control prediction. 
Secondly, BN is a method that is capable to be 
learned by integrating opinion of experts, but in this 
study it was done exclusively with data learning. To 
ensure a more reliable and a more generalized 
network for prediction, a proposed BN model be 
brainstormed with medical experts from the intensive 
care units, and if necessary, be validated with cross-
unit experts such as the concern of comorbidities.  
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